Garheng Kong
- Biomedical Engineering top 2%
- Biomaterials top 0.5%
- Molecular Biology top 10%
- Materials Chemistry
- Radiology, Nuclear Medicine and Imaging top 5%
- Co-authors
- Mark W. DewhirstRod D. BraunGopal AnyarambhatlaDavid NeedhamAshutosh ChilkotiDan E. MeyerByung-Cheol ShinWilliam P. Petros
- Topics
- Nanoparticle-Based Drug Delivery (5 papers)RNA Interference and Gene Delivery (3 papers)Nanoplatforms for cancer theranostics (3 papers)
- Journals
- Nature BiotechnologyJournal of Controlled ReleasePubMed
- Partner nations
- United States
In The Last Decade
Garheng Kong
8 papers receiving 2.5k citations
Hit Papers
Peers
Comparison fields: 5 of 98
- Biomedical Engineering 1.6k
- Biomaterials 1.5k
- Molecular Biology 832
- Materials Chemistry 266
- Radiology, Nuclear Medicine and Imaging 231
Countries citing papers authored by Garheng Kong
This map shows the geographic impact of Garheng Kong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Garheng Kong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Garheng Kong more than expected).
Fields of papers citing papers by Garheng Kong
This network shows the impact of papers produced by Garheng Kong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Garheng Kong. The network helps show where Garheng Kong may publish in the future.
Co-authorship network of co-authors of Garheng Kong
This figure shows the co-authorship network connecting the top 25 collaborators of Garheng Kong. A scholar is included among the top collaborators of Garheng Kong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Garheng Kong. Garheng Kong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 339 | |
| 2 | Characterization of the effect of hyperthermia on nanoparticle extravasation from tumor vasculature. | 382 |
| 3 | Targeting a genetically engineered elastin-like polypeptide to solid tumors by local hyperthermia. | 191 |
| 4 | A new temperature-sensitive liposome for use with mild hyperthermia: characterization and testing in a human tumor xenograft model.breakdown → | 627 |
| 5 | Hyperthermia enables tumor-specific nanoparticle delivery: effect of particle size.breakdown → | 525 |
| 6 | Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release. | 423 |
| 7 | 79 | |
| 8 | [A study on pharmacokinetics of 3H-mitoxantrone in experimental animals]. | 1 |
About Garheng Kong
Garheng Kong is a scholar working on Biomaterials, Molecular Medicine and Biophysics, having authored 8 papers that have together received 2.6k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (5 papers), RNA Interference and Gene Delivery (3 papers) and Nanoplatforms for cancer theranostics (3 papers). The work is most often cited by research in Biomaterials (1.5k citations), Molecular Medicine (179 citations) and Biomedical Engineering (1.6k citations). Garheng Kong has collaborated with scholars based in United States. Frequent co-authors include Mark W. Dewhirst, Rod D. Braun, Gopal Anyarambhatla, David Needham, Ashutosh Chilkoti, Dan E. Meyer, Byung-Cheol Shin, William P. Petros, O. Michael Colvin and Michael R. Zalutsky. Their work appears in journals such as Nature Biotechnology, Journal of Controlled Release and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.